In QASC it is unclear which of the 3 interventions contributed to mortality reduction.37 In GIST‐UK >50% of patients had baseline glucose of <8.0 mmol/L, below the threshold for insulin treatment used in the present study. The gene discussed is INS; the disease is gastrointestinal stromal tumor.